Screener / SEC EDGAR /CIK 0001046257 /10-K filed Feb 17, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Packaged Foods

Ingredion Inc INGR

Compare with peers Embed
The 10-K against last year's

131 changes: 17 added, 16 removed, 96 reworded, 2 quiet changes

10-K Feb 17, 2026 vs Feb 20, 2025

10-K 0001628280-26-008603 (Feb 17, 2026) vs 10-K 0001046257-25-000018 (Feb 20, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

85 paragraphs · 14 new · 42 reworded · 7 gone · 10-K Feb 17, 2026 against Feb 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 79 · 50% changed Every version of it
Operating difficulties at our manufacturing facilities and liabilities relating to product safety and quality could These factors may adversely affect impact our operating results, financial condition, cash flows and prospects. We could also experience delays in reporting our financial results.
Paragraph 2 · 48% changed Every version of it
Changes in consumer practices, preferences, price sensitivity, behaviors, demand and perceptions, including with respect to products developed through biotechnology, perceptions may lessen reduce the demand for our products, which could reduce our sales and profitability and harm our business. products.
Paragraph 32 · 48% changed Every version of it
An inability to contain costs costs, manage working capital, or achieve budgets, including completing planned maintenance and working capital investment projects on time and on budget, could adversely affect our future profitability, profitability or cash flows and growth. flows.
Paragraph 67 · 37% changed Every version of it
We continue to issue debt securities to finance capital expenditures, working capital and acquisitions, and for other general corporate purposes. Sustained or higher interest rates, tighter or uneven credit conditions, and capital market volatility could increase our cost of borrowing, constrain our access to liquidity, and heighten refinancing risk as debt maturities approach. An increase in interest rates in the general economy could result in an increase in our borrowing costs for these financings, as well as under our revolving credit facility, which bears interest at an unhedged floating rate. We have senior notes with $499 million principal, net of discounts, which incur interest at 3.2 percent annually, that mature on October 1, 2026. If we are unable to secure refinancing of these notes at a favorable interest rate, our financial results and cash flows could be adversely affected.
Paragraph 37 · 34% changed Every version of it
There is a global concern that carbon dioxide and other greenhouse gases in the atmosphere may have an adverse effect on global temperatures, weather patterns and the frequency and severity of natural disasters. The increasing concern over climate change could result in new domestic or international legal requirements for us to reduce greenhouse gas emissions and other environmental impacts of our operations, improve our energy efficiency, or undertake sustainability measures that exceed those we currently pursue. Furthermore, such measures may result in the taxation of greenhouse gas emissions. Any such regulatory requirements could cause disruptions in the manufacture of our products and result in increased capital, procurement, manufacturing and distribution costs. Our reputation could be harmed if we fail, or are seen as having failed, to respond responsibly and effectively to changes in legal and regulatory measures adopted to address climate change. The occurrence of any of the foregoing matters could adversely affect our operating results, financial condition, cash flows and prospects and could require us to devote significant resources to rebuild our reputation.
Paragraph 4 · 34% changed Every version of it
The demand for Some of our customers, including those engaged in the food products, including agricultural products developed through biotechnology, is often affected by changes in consumer practices and tastes, national, regional and local economic conditions. For instance, changes in prevailing health or dietary preferences causing consumers beverage industries, may incur significant costs to avoid food products that contain sweetener products, including high fructose corn syrup, and genetically modified products, in favor of foods that are perceived as being healthier or pose unknown risks to the environment, have negatively affected our sales and profitability. Increasing address increasing concern among consumers, public health professionals and government agencies about the potential health concerns impacts associated with obesity and inactive lifestyles represent a significant cost to some of our customers, including those engaged in the food and soft drink industries, and continue to lifestyles, which could materially affect price sensitivity and the demand for our products. Similarly, the increasing availability, use and acceptance of weight loss medications, including the expanded use of medications designed for weight loss in people without diabetes, may reduce sales of food and beverage products that contain our ingredients, since the medications regulate appetite and may reduce the overall amount of food and beverages consumed.
Paragraph 41 · 34% changed Every version of it
We regularly review potential acquisitions of acquisitions, joint ventures, or strategic alliances with candidates who possess complementary businesses, technologies, services, or products, as well as products. In addition, we regularly review potential divestitures or based on our strategic alliances. priorities, benefits, impacts, and opportunities of such transactions. We have completed several such acquisitions and strategic alliances divestitures in recent years and such as the sale of our South Korea business on in February 1, 2024. 2024, for which we are still receiving consideration payments. In September 2025, we entered into a definitive agreement to sell a 51 percent ownership interest in the Pakistan business, which we amended in December 2025 to grant Nishat Group an option to purchase additional shares for commensurate consideration per share. We may be unable to find suitable acquisition candidates, purchasers for operations we may wish to sell, or appropriate partners with whom to make investments, form partnerships partnerships, joint ventures or strategic alliances. Even if we identify appropriate acquisition, divestiture divestiture, investment or alliance candidates, regulatory reviews may prevent a transaction from being consummated, or we may be unable to complete acquisitions, divestitures divestitures, investments or alliances on favorable terms, on time, on budget, or at all.
Paragraph 44 · 33% changed Every version of it
Additionally, we participate in several joint ventures, some of which are intended to be long-term investments, in which we have limited control over governance, financial reporting, and operations. As a result, we face operating, financial, legal and other risks relating to these investments, including risks related to the financial strength of our joint venture partners or their willingness to provide adequate funding for the joint venture, differences in objectives between us and our partners, legal and compliance risks relating to actions or omissions of the joint venture or our partners, and the risk that we will be unable to resolve disputes with the joint venture partners. As a result, these investments may contribute significantly less than we anticipate to our earnings and cash flows.

MD&A

69 paragraphs · 3 new · 50 reworded · 9 gone · 10-K Feb 17, 2026 against Feb 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 60 · 48% changed
We have identified below the most critical accounting policies upon which the financial statements are based and that involve our most complex and subjective decisions and assessments. Our senior management has discussed the development, selection and disclosure of these policies with members of the Audit Committee of our Board of Directors. These accounting policies are described in the Notes to the Consolidated Financial Statements. The discussion that follows should be read in conjunction with the Consolidated Financial Statements and related notes included elsewhere in this annual report on Form 10-K.
Paragraph 26 · 47% changed
Operating income (loss). loss. All Other operating (loss) increased loss improved to $(22) a loss of $2 million for 2024 2025 compared to $(2) a loss of $22 million for 2023. 2024. The increase improvement was primarily driven due to improvements in our Protein Fortification business partly offset by the sale of lower operating profits in our South Korea Pakistan business.
Paragraph 24 · 43% changed
Operating income. T&HS F&II–U.S./Canada operating income decreased 11 16 percent to $350 $315 million for 2024 from $394 2025 compared to $373 million for 2023. 2024. The decrease was primarily driven by unfavorable price mix lower volumes and the carry-forward production challenges at one of higher cost inventory from 2023, partially offset by improved volumes. our large manufacturing facilities.
Paragraph 48 · 42% changed
(iii)This amount (iv)In 2025, we recorded $9 million of pre-tax benefits related to insurance recoveries and a favorable judgment related to certain indirect taxes. In 2024, this primarily related to tornado damage incurred at a U.S. warehouse in 2024. In 2023, we recorded pre-tax charges of $5 million primarily related to the impacts of a U.S.-based work stoppage, which was partially offset by $4 million of insurance recoveries. warehouse.
Paragraph 56 · 42% changed
(iii)This amount (iv)In 2025, we recorded $9 million of pre-tax benefits related to insurance recoveries and a favorable judgment related to certain indirect taxes. In 2024, this primarily related to tornado damage incurred at a U.S. warehouse in 2024. In 2023, we recorded pre-tax charges of $5 million primarily related to the impacts of a U.S.-based work stoppage, which was partially offset by $4 million of insurance recoveries. warehouse.
Paragraph 13 · 42% changed
Financing costs. Financing costs decreased 66 5 percent to $37 million for 2025 compared to $39 million for 2024 compared to $114 million for 2023. 2024. The decrease was primarily due to the pay down of borrowings lower interest expense on lower average outstanding under our commercial paper program, as well as debt balances during 2025 in comparison to 2024, partially offset by foreign exchange impacts. losses in 2025 compared to foreign exchange gains in 2024.
Paragraph 11 · 41% changed
Other operating (income) expense, (income), net. Other operating (income) expense, (income), net was $24 million for 2025 compared to $1 million of income for 2024 compared to $8 million of income for 2023. Both 2024 and 2023 income were 2024. The increase was primarily attributable to reduced fees from the sale of our share of receivables, indirect tax benefits recognized in Brazil, and higher income in from our Argentina joint venture. equity method investments.
Paragraph 12 · 38% changed
Restructuring/impairment charges. Restructuring and impairment charges increased decreased to $21 million for 2025 compared to $127 million for 2024. The 2024 from $11 million for 2023, which charges were primarily reflected impairment charges related to impairments due to the cessation of operations at our manufacturing facilities in Vanscoy, Canada, Canada; Goole, United Kingdom, Kingdom; and Alcantara, Brazil manufacturing facilities. The 2023 Brazil, in addition to restructuring costs from our January 1, 2024 resegmentation. In 2025, we recorded impairment charges were primarily related to impairments of our for equity method investments. investments and decommissioning costs for previously announced plant closures and restructuring activities that occurred during the year.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors196 words changed in this paragraph; it is 35% similar to last year's version.
The demand for food products, products that contain our ingredients, including agricultural products developed through biotechnology, is often may be adversely affected by changes in consumer practices practices, preferences, price sensitivities, tastes, and tastes, national, regional and local economic conditions. For instance, changes in prevailing health or dietary Consumer preferences causing and purchasing behaviors relating to food and beverage products continue to evolve and may be influenced by nutrition guidance, education campaigns, and public‑health initiatives. These developments may cause consumers to avoid food or beverage products that contain sweetener products, including added sugars, sweeteners, carbohydrates, highly-processed foods, high fructose corn syrup, and genetically modified products, or biotechnology‑derived ingredients, in favor of foods or beverages that are perceived as being healthier “healthier” or pose unknown risks of contributing to the environment, a “cleaner” ingredient label. These perceptions have negatively affected our sales and profitability. Increasing concern among consumers, public health professionals and government agencies about the potential health concerns associated with obesity and inactive lifestyles represent a significant cost to demand for some of our customers, including those engaged in the food and soft drink industries, and continue to materially affect demand for our products. Similarly, the increasing availability, use and acceptance of weight loss medications, including the expanded use of medications designed for weight loss in people without diabetes, may reduce sales of food and beverage products that contain our ingredients, since the medications regulate appetite and may reduce the overall amount of food and beverages consumed. ingredients.

Source: Item 1A, 10-K 0001628280-26-008603 vs Item 1A, 10-K 0001046257-25-000018

Accounting Policies144 words changed in this paragraph; it is 40% similar to last year's version.
In August 2023, the FASB issued ASU On January 1, 2025, we adopted Accounting Standard Update (“ASU”) No. 2023-05, Business Combinations - Joint Combinations—Joint Venture Formations (Subtopic 805-60). This ASU requires that 805-60), on a prospective basis. Under this standard, a joint venture must apply a new basis of accounting upon formation. By applying a new basis of accounting, a joint venture, upon formation, must recognize and formation by initially measure measuring its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance). This ASU is effective prospectively for all We applied the new standard to the Agrana joint venture formations with a formation date on or after January 1, 2025. A joint venture that venture, described in Note 3. The effect of adoption of the new standard was formed before January 1, 2025 may elect not material to apply the amendments retrospectively. We intend to adopt this ASU at the beginning of our 2025 fiscal year on a prospective basis for any joint ventures we enter in the future. We do not believe this ASU will have a material impact on our future Consolidated Financial Statements.

Source: Item 8, Note 1 – Description of the Business and Summary of Significant Accounting Policies, 10-K 0001628280-26-008603 vs Item 8, Note 1 – Description of the Business and Summary of Significant Accounting Policies, 10-K 0001046257-25-000018

MD&A82 words changed in this paragraph; it is 39% similar to last year's version.
Restructuring/impairment charges. Restructuring and impairment charges increased decreased to $21 million for 2025 compared to $127 million for 2024. The 2024 from $11 million for 2023, which charges were primarily reflected impairment charges related to impairments due to the cessation of operations at our manufacturing facilities in Vanscoy, Canada, Canada; Goole, United Kingdom, Kingdom; and Alcantara, Brazil manufacturing facilities. The 2023 Brazil, in addition to restructuring costs from our January 1, 2024 resegmentation. In 2025, we recorded impairment charges were primarily related to impairments of our for equity method investments. investments and decommissioning costs for previously announced plant closures and restructuring activities that occurred during the year.

Source: Item 7, 10-K 0001628280-26-008603 vs Item 7, 10-K 0001046257-25-000018

Legal Proceedings21 words changed in this paragraph; it is 87% similar to last year's version.
In September 2022, following certain air emissions testing Ingredion performed at our Bedford Park, Illinois manufacturing facility, we reported to the Illinois Environmental Protection Agency (the “Illinois EPA”) that certain emissions had exceeded applicable limits under an air emissions permit. On February 8, 2023, the Illinois EPA issued to us a Notice of Violation with respect to the matter addressed in our report. Violations of the Illinois environmental statute could result in the imposition of civil or criminal monetary penalties. We are engaged in discussions with the Illinois EPA regarding this matter.

Source: Item 3, 10-K 0001628280-26-008603 vs Item 3, 10-K 0001046257-25-000018

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of INGR's Risk Factors and MD&A, 10-K Feb 17, 2026 against 10-K Feb 20, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
The demand for food products that contain our ingredients, including agricultural products developed through biotechnology, may be adversely affected by changes in consumer practices, preferences, price sensitivities, tastes, and national, regional and local economic conditions. Consumer preferences and purchasing behaviors relating to food and beverage products continue to evolve and may be influenced by nutrition guidance, education campaigns, and public‑health initiatives. These developments may cause consumers to avoid food or beverage products that contain added sugars, sweeteners, carbohydrates, highly-processed foods, high fructose corn syrup, or biotechnology‑derived ingredients, in favor of foods or beverages that are perceived as being “healthier” or of contributing to a “cleaner” ingredient label. These perceptions have negatively affected the demand for some of our ingredients.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
As a result, certain customers may reformulate products, reduce volumes, or discontinue products that incorporate certain of our ingredients, including sweeteners, starches, texturizers, and other specialty ingredients, or seek alternative ingredients from our competitors. Such changes could reduce demand for our products, increase pricing pressure, require additional investment by us in reformulation and product development, influence customer procurement decisions and mix, or result in underutilization of manufacturing assets. While we continue to invest in innovation and solutions that we believe aligns with evolving customer and consumer needs, these efforts may not fully offset those adverse demand, pricing, or cost impacts. Any of the foregoing could materially and adversely affect our production volumes, profit margins, results of operations, financial condition, and cash flows.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
Geopolitical developments, tensions, threats or conflicts could harm our business by adversely affecting the availability and prices of raw materials and energy supplies; disrupting global markets, supply chains, and foreign exchange and interest rates, and causing changes in migration patterns.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
Ingredion operates a global manufacturing and sourcing network and relies on agricultural commodities, energy, logistics services, and international customers, suppliers, and other counterparties. Our operations could be adversely affected by actions taken in connection with cross-border actions by the governments of countries in which we conduct business or through which our products may travel. Heightened geopolitical tensions, a perceived reduction in multilateral security cooperation, or changes to geopolitical policies or relationships, could contribute to increased or more volatile energy or freight costs, shortages or delays in raw materials or other inputs, sanctions or export controls, changes in trade policy, currency volatility, and reduced customer demand in certain markets. In addition, these factors may spur secondary or tertiary conflicts with or between other countries or regions, which could increase volatility in the availability and prices of raw materials and energy supplies, create supply chain disruptions or delays, or reduce customer or consumer demand.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
These developments, together with ongoing conflicts and tensions in other regions, including the ongoing conflict between Russia and Ukraine and the continuing situation in the Middle East, could disrupt international trade flows, energy and commodity markets, transportation networks, and financial markets. Certain of these locations are in regions that provide sources of raw material and energy supplies for both us and some companies whose products we distribute, particularly in our Texture & Healthful Solutions segment and our Pakistan business.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
In addition, heightened geopolitical uncertainty may increase the risk of cyber incidents, disrupt capital markets, and adversely affect foreign exchange and interest rate conditions, all of which could negatively affect our financial results. While we seek to mitigate these risks through diversification, risk management, and contingency planning, such efforts may not be successful. Any of the foregoing developments could materially and adversely affect our results of operations, financial condition, and cash flows.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
Our ability to expand our business may suffer if we do not keep pace with technological developments and continue to offer innovative products, including more sustainable production methods.
Read it in 10-K Feb 17, 2026 at sec.gov
Show the other 49
AddedRisk Factors
In addition, recent and potential future changes in the priorities and scope of U.S. federal or state regulatory agencies may increase legal, regulatory, and operational uncertainty for us, including with respect to environmental regulation, immigration enforcement and labor availability, trade policy, and tax and fiscal legislation. Such changes could increase
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
Our increasing use of artificial intelligence and other advanced technologies, and our reliance on third‑party technology providers, could expose us to operational, legal, regulatory, cybersecurity, and reputational risks that may adversely affect our business.
Read it in 10-K Feb 17, 2026 at sec.gov
RemovedRisk Factors
Geopolitical conflicts and actions arising from them may have an adverse effect on the availability and prices of raw materials and energy supplies, cause supply chain disruptions, or contribute to volatility in foreign exchange and interest rates.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedRisk Factors
Our business may be adversely affected by geopolitical conflicts, including the ongoing conflict between Russia and Ukraine, and conflict in the Middle East. Our operations in Russia and Ukraine accounted for less than one half of one percent of our net sales in 2024, but these locations are in regions that provide sources of raw material and energy supplies for both us and some companies whose products we distribute. Economic sanctions and export control measures imposed on Russia and designated Russian enterprises, Belarus and certain regions of Ukraine have resulted in increased volatility in the availability and prices of such raw materials and energy supplies. In addition, sanctions and macroeconomic effects of geopolitical conflicts have contributed to greater volatility in foreign exchange and interest rates that affect our financial results. Developments relating to geopolitical conflicts might result in a continuation of these impacts and in other impacts that could adversely affect our business or results of operations.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedRisk Factors
The success of our business depends on the continuing innovation, research, development, formulation, maintenance and operation of our products and services, including more sustainable production.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedRisk Factors
If we are unable to contain our operating costs and maintain the productivity and reliability of our production facilities, our profitability and growth could be adversely affected.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedRisk Factors
In particular, our operations could be adversely affected by actions taken in connection with cross-border disputes by the governments of countries in which we conduct business.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedRisk Factors
growth opportunities, we may not be able to achieve our desired operating efficiencies and expansion plans, which may adversely impact our competitiveness and our results of operations.
Read it in 10-K Feb 20, 2025 at sec.gov
RewordedRisk Factors
Increasing Some of our customers, including those engaged in the food and beverage industries, may incur significant costs to address increasing concern among consumers, public health professionals and government agencies about the potential health concerns impacts associated with obesity and inactive lifestyles represent a significant cost to some of our customers, including those engaged in the food and soft drink industries, and continue to lifestyles, which could materially affect price sensitivity and the demand for our products.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
As a result, we face operating, financial, legal and other risks relating to these investments, including risks related to the financial strength of our joint venture partners or their willingness to provide adequate funding for the joint venture, differences in objectives between us and our partners, legal and compliance risks relating to actions or omissions of the joint venture or our partners, and the risk that we will be unable to resolve disputes with the joint venture partners.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
We may If we do not successfully identify and complete acquisitions, divestitures, or strategic alliances on favorable terms or achieve anticipated synergies relating to any acquisitions or alliances, and such transactions we could result in experience unforeseen operating difficulties difficulties, additional expenses and expenditures and require the diversion of significant management resources. resources from our ongoing business.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Changes in consumer practices, preferences, price sensitivity, behaviors, demand and perceptions, including with respect to products developed through biotechnology, perceptions may lessen reduce the demand for our products, which could reduce our sales and profitability and harm our business. products.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
An inability to contain costs costs, manage working capital, or achieve budgets, including completing planned maintenance and working capital investment projects on time and on budget, could adversely affect our future profitability, profitability or cash flows and growth. flows.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
If we are unable to generate sufficient cash flows or raise sufficient additional funds to cover our capital expenditures or to finance strategic growth opportunities, we may not be able to achieve our desired operating efficiencies and expansion plans, which may adversely impact our competitiveness and our results of operations.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
If the strength value of the U.S. dollar continues, changes versus a foreign currency, it could take us an extended period to fully recapture offset the impact of a loss of foreign currency value versus the U.S. dollar. any such changes.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
We regularly review potential acquisitions of acquisitions, joint ventures, or strategic alliances with candidates who possess complementary businesses, technologies, services, or products, as well as potential divestitures or strategic alliances. products.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
We have completed several such acquisitions and strategic alliances divestitures in recent years and such as the sale of our South Korea business on in February 1, 2024. 2024, for which we are still receiving consideration payments.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Country capital controls, such as those imposed in Pakistan and Argentina, may prevent the repatriation of dividends or payments due to us from our investments and subsidiaries or transfer of consideration payments for divestitures, such our pending agreement to sell an interest in our Pakistan business, in countries that impose such controls.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Economic conditions may adversely impact demand for our products, reduce our access to credit, affect our investment returns and cause our customers and others with whom we do business to suffer financial hardship, all of which could adversely impact our business, results of operations, financial condition and cash flows. hardship.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
We have operated sell products to, purchase inputs from, and operate in foreign countries and where we transact with foreign currencies for many years, currencies, and where our results are subject to foreign currency exchange fluctuations.
Read it in 10-K Feb 17, 2026 at sec.gov
Quiet changesRisk Factors
While Although the corn and soy futures contracts or hedging positions are intended to minimize the effect of volatility of corn costs on operating profits, the hedging activity can result in losses, some of which may be material.
Read it in 10-K Feb 17, 2026 at sec.gov
Quiet changesRisk Factors
Although we require our third-party vendors contractually to maintain a level of security that is acceptable to us and work closely with key vendors to address potential and actual security concerns and attacks, not all confidential, proprietary, or personal information may not be protected on their systems.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
On November 17, 2025, we entered into a lease for a new Global Innovation headquarters facility that will be built in Bridgewater, New Jersey, where we currently lease another facility for research and operations. When the Global Innovation headquarters construction is substantially complete and ready for our use, which we estimate will be in the first
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
half of 2028, subject to environmental conditions, structural dependencies and regulatory approvals, we will begin lease payments for a term of 25 years. Lease payments will be primarily based on the cost to construct the facility, which we estimate will be approximately $145 million.
Read it in 10-K Feb 17, 2026 at sec.gov
RemovedMD&A
We have not provided foreign withholding taxes, state income taxes and federal and state taxes on foreign currency gains/losses on accumulated undistributed earnings of certain foreign subsidiaries because these earnings are considered to be permanently reinvested. It is not practicable to determine the amount of the unrecognized deferred tax liability related to the undistributed earnings. We do not anticipate the need to repatriate funds to the U.S. to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
We and our subsidiaries sponsor noncontributory defined benefit pension plans (qualified and non-qualified) covering a portion of employees in the U.S. and Canada, and certain employees in other countries. We also provide healthcare and life insurance benefits for retired employees in the U.S., Canada and Brazil. In order to measure the expense and obligations associated with these benefits, our management must make a variety of estimates and assumptions, including discount rates, expected long-term rates of return, rate of compensation increases, employee turnover rates, retirement rates, mortality rates and other factors. We review our actuarial assumptions on an annual basis as of December 31 (or more frequently if a significant event requiring remeasurement occurs) and modify our assumptions based on current rates and trends when it is appropriate to do so. The effects of modifications are recognized immediately on the Consolidated Balance Sheets but are generally amortized into non-operating earnings over future periods, with the deferred amount recorded in accumulated other comprehensive loss (“AOCL”). We believe the assumptions utilized in recording our obligations under our plans, which are based on our experience, market conditions and input from our actuaries, are reasonable. We use third-party specialists to assist management in evaluating our assumptions and estimates, as well as to appropriately measure the costs and obligations associated with our retirement benefit plans. Had we used different estimates and assumptions for these plans, our retirement benefit obligations and related expense could vary from the actual amounts recorded and such differences could be material. Additionally, adverse changes in investment returns earned on pension assets and discount rates used to calculate pension and postretirement benefit related liabilities or changes in required funding levels may have an unfavorable impact on future expense and cash flow. Net periodic pension and postretirement benefit cost for all of our plans was $9 million in 2024 and $12 million in 2023.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
We determine our assumption for the discount rate used to measure year-end pension and postretirement obligations based on high-quality fixed-income investments that match the duration of the expected benefit payments, which has been benchmarked using a long-term, high-quality AA corporate bond index. We use a full yield curve approach in the estimation of the service and interest cost components of benefit cost by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. The weighted average discount rate used to determine our obligations under U.S. pension plans as of December 31, 2024 and 2023 was 5.64 percent and 5.00 percent. The weighted average discount rate used to determine our obligations under non-U.S. pension plans as of December 31, 2024 and 2023 was 5.42 percent and 5.24 percent. The weighted average discount rate used to determine our obligations under our postretirement plans as of December 31, 2024 and 2023 was 7.75 percent and 7.37 percent.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
A one percentage point decrease in the discount rates at December 31, 2024, would have increased the accumulated benefit obligation and projected benefit obligation by the following amounts (in millions):
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
U.S. Pension Plans Accumulated benefit obligation $27 Projected benefit obligation 27 Non-U.S. Pension Plans Accumulated benefit obligation $18 Projected benefit obligation 20 Postretirement Plans Accumulated benefit obligation $6
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
Our investment approach and related asset allocation for the U.S. and Canadian plans is a liability-driven investment approach by which a higher proportion of investments will be in interest-rate sensitive investments (fixed income) under an active-management approach. The approach seeks to protect the current funded status of the plans from market volatility with a greater asset allocation to interest-rate sensitive assets, which is expected to reduce volatility in plan-funded status by more closely matching movements in asset values to changes in liabilities.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
Our current investment policy for our pension plans is to balance risk and return through diversified portfolios of actively managed equity index instruments, fixed income index securities and short-term investments. Maturities for fixed income securities are managed so that sufficient liquidity exists to meet near-term benefit payment obligations. The asset allocation is reviewed regularly, and portfolio investments are rebalanced to the targeted allocation when considered appropriate or to raise sufficient liquidity when necessary to meet near-term benefit payment obligations. For 2024 net periodic pension cost, we assumed an expected long-term rate of return on assets, which is based on the fair value of plan assets, of 5.50 percent for U.S. plans and approximately 4.58 percent for Canadian plans. In developing the expected long-term rate of return assumption on plan assets, which consist mainly of U.S. and Canadian debt and equity securities, management evaluated historical rates of return achieved on plan assets and the asset allocation of the plans, input from our independent actuaries and investment consultants, and historical trends in long-term inflation rates. Projected return estimates made by such consultants are based upon broad equity and bond indices. We also maintain several funded pension plans in other international locations. The expected returns on plan assets for these plans are determined based on each plan’s investment approach and asset allocations. A hypothetical 25 basis point decrease in the expected long-term rate of return assumption would increase 2025 net periodic pension cost for the U.S. and Canadian plans by approximately $1 million each.
Read it in 10-K Feb 20, 2025 at sec.gov
RemovedMD&A
Healthcare cost trend rates are used in valuing our postretirement benefit obligations and are established based on actual health care cost trends and consultation with actuaries and benefit providers. At December 31, 2024, the health care cost trend rate assumptions for the next year were 8.40 percent for the U.S. plans, 5.25 percent for the Canadian plans, and 8.42 percent for the Brazilian plans.
Read it in 10-K Feb 20, 2025 at sec.gov
RewordedMD&A
Restructuring and resegmentation charges costs 13 2 18 5 1 — Net gain (gain) on sale of business — — (90) (4) — Impairment charges 10 3 109 — Other matters (9) (2) 6 1 1 Tax item–Mexico — Impairment charges 109 14 — 10 3 (18) Other tax matters — — — (4) — 6 Tax item-Mexico — (18) — 15 Adjusted non-GAAP Non-GAAP $ 988 $ 255 25.8% $ 974 $ 257 26.4% $ 851 $ 212 24.9%
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
The increase decrease in the effective tax rate was primarily driven by the change in value of the Mexican peso against the U.S. dollar, dollar in 2025, an unfavorable legal judgement ruling by tax authorities that generated a multi-year tax contingency in 2024, and related reserve on transfer pricing matters, the elimination impairment of certain tax incentives in Brazil, and a valuation allowance on investments. an equity method investment during 2024.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Provision for income taxes 238 277 188 Other non-operating expense 5 3 4 Financing costs 37 39 114 Restructuring and resegmentation charges costs (i) 13 18 1 Net gain (gain) on sale of business (ii) — (90) — Impairment charges (iii) 8 109 Other matters (iii) (iv) (9) 6 1 Impairment charges (iv) 109 10 Income taxes (at adjusted effective rates of 26.4% 25.8% and 24.9%) (iv) 26.4%, respectively) (v) (265) (268) (241) Adjusted operating income, net of tax (b) 763 748 728 Short-term debt 48 44 448 Long-term debt 1,742 1,787 1,740 Less:
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Year Ended Year Ended December 31, 2024 2025 December 31, 2023 2024 (dollars in millions) Income before Income Taxes (a) Provision for Income Taxes (b) Effective Income Income before Income Taxes (a) Provision for Effective Income Taxes Income Taxes Income Tax Income Taxes Income Taxes (b) Effective Income Tax Rate (b/a) Tax Rate (b/a) As reported Reported $ 974 $ 238 24.4% $ 931 $ 277 29.8% $ 839 $ 188 22.4% Adjustments:
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
We used $765 $491 million of cash for financing activities in 2024 2025 compared to cash used for financing activities of $569 $765 million in 2023. 2024, primarily because we did not borrow under our commercial paper program in 2025, while we repaid $327 million of commercial paper borrowings during 2024.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Depreciation and amortization 222 214 219 Financing costs 37 39 114 Other non-operating expense 5 3 4 Restructuring and resegmentation costs (i) 7 18 2 Net gain (gain) on sale of business (ii) — (90) — Impairment charges (iii) 8 109 Other matters (iii) (iv) (9) 6 1 Impairment charges (iv) 109 10 Adjusted EBITDA (c) $ 1,244 $ 1,230 $ 1,189 Net Debt to Income before income tax ratio (a ÷ b) 0.8 0.9 2.1 Net Debt to Adjusted EBITDA ratio (a ÷ c) 0.6 0.7 1.5
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
(i)In 2024, 2025, we recorded $18 $13 million of pre-tax net restructuring and resegmentation charges primarily related to accelerated depreciation and decommissioning costs for previously announced plant closures and restructuring activities that occurred during the year and the resegmentation of the business that was effective January 1, 2024. year.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
(i)In 2024, 2025, we recorded $18 $13 million of pre-tax net restructuring and resegmentation charges primarily related to accelerated depreciation and decommissioning costs for previously announced plant closures and restructuring activities that occurred during the year and the resegmentation of the business that was effective January 1, 2024. year.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Our cash used for investing activities decreased increased to $444 million in 2025 from $47 million in 2024 from $329 million in 2023, primarily due to the 2024, which reflected proceeds from the sale of our South Korea business of $255 million, partially offset by decreased capital expenditures million in February 2024.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
(iv)In 2024, we recorded $109 million of pre-tax impairment charges that primarily related to our plans to cease operations at our Vanscoy, Canada, Alcantara, Brazil, Brazil; and Goole, United Kingdom manufacturing facilities, Kingdom, and impairment charges on our equity method investments.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Cash and cash equivalents (1,030) (997) (401) Short-term investments (3) (11) (8) Total net debt 757 823 1,779 Share-based payments subject to redemption 64 60 55 Total redeemable non-controlling interests 7 43 7 Total equity 4,295 3,823 3,552 Total net debt and equity $ 5,123 $ 4,713 $ 5,429 Average current and prior year Total net debt and equity (c) $ 4,918 $ 5,071 $ 5,468 Return on Invested Capital (a ÷ c) 15.0 % 12.9 % 11.9 % Adjusted Return on Invested Capital (b ÷ c) 15.5 % 14.8 % 13.3 %
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
The decrease increase was primarily due to an increase in volumes in our Sugar Reduction businesses and an increase in price mix in our Pakistan business, partially offset by lost volumes from the sale of our South Korea business on February 1, 2024.
Read it in 10-K Feb 17, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INGR/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.